UnknownNot Applicable

Metabolomic Study of All-age Cardiomyopathy

China1,000 participantsStarted 2016-10

Plain-language summary

This study aims to 1)characterize the differentially expressed metabolites between cardiomyopathy patients and healthy controls,2)identify the specific biomarkers associated with outcomes or risk evaluation in patients with different cardiomyopathies in a follow-up of a cohort and 3)to determine whether differentially expressed may affect the pathological process of cardiomyopathies . Standardized protocols will be used for the assessment of medical history and examinations, laboratory biomarkers, and the collection of blood plasma.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Subjects who was diagnosed as cardiomyopathy by medical history, clinical symptoms, laboratory tests including ECG, echocardiography.
✓. Subject understands study requirements aand agrees to sign an informed consent form prior to any study procedures

Exclusion criteria

✕. Endocrine disease known to cause heart muscle disease (including infants of diabetic mothers)
✕. History of rheumatic fever
✕. Toxic exposures known to cause heart muscle disease (anthracyclines, mediastinal radiation, iron overload or heavy metal exposure)
✕. HIV infection or born to an HIV positive mother
✕. Kawasaki disease
✕. Immunologic disease
✕. Uremia, active or chronic
✕. Abnormal ventricular size or function that can be attributed to intense 9.physical training or chronic anemia

What they're measuring

Result of echocardiography

Timeframe: three year

Trial details

NCT IDNCT03061994

SponsorBeijing Institute of Heart, Lung and Blood Vessel Diseases

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-10

Contact for this trial

Jie Du, PhD

jiedubj@126.com

View on ClinicalTrials.gov More Dilated Cardiomyopathy trials